NOS3 and juvenile polyposis syndrome: The strong points of the work are the novelty of genotyping NOS2 and NOS3 polymorphisms, the inclusion of a good number of PJI patients and the use of patients with orthopaedic prosthesis lasting > 16 years as controls.